Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide

About this update from Heartflow, Inc.

[{"type":"image","alt":"Heartflow Holding, Inc.","displaySize":"","headline":null,"caption":"Heartflow Holding, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":52,"url":"https://media.zenfs.com/en/globenewswire.com/0b319a52196d6c9eaeb104c9e1d19600"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/QNDJd1ZjyMR4MeMNf8OLHg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTczO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/0b319a52196d6c9eaeb104c9e1d19600","width":300,"height":52}},"lazy":false},{"type":"text","content":"Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patients","length":185,"tagName":"p"},{"type":"text","content":"MOUNTAIN VIEW, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis will be covered by UnitedHealthcare across all lines of business, including Commercial, Medicare Advantage, and Community plans. UnitedHealthcare is the first insurer to update its policies to cover Heartflow Plaque Analysis to fully align with the guidelines recently issued by radiology benefit manager EviCore.","length":492,"tagName":"p"},{"type":"text","content":"“UnitedHealthcare’s decision to cover Heartflow Plaque Analysis nationwide is a tremendous step in advancing patient access to our proven AI-driven plaque technology,” said John Farquhar, President and CEO of Heartflow. “We are pleased that this major commercial payer recognizes the innovation and value that Heartflow’s technology can provide to its members and healthcare providers in diagnosing and managing coronary artery disease. This decision will increase access for early detection and quantification of plaque using our precision Plaque Analysis tool, setting a new standard for cardiovascular care coverage.”","length":620,"tagName":"p"},{"type":"text","content":"The updated coverage will become effective October 1, 2025 for patients with acute or stable chest pain and mild-to-moderate narrowing of coronary arteries (1-70% stenosis) found on coronary computed tomography angiography (CCTA). Expanded access will allow for greater adoption of Heartflow Plaque Analysis for clinicians to incorporate into their diagnostic and patie...

More updates from Heartflow, Inc.